Dashurie Neziri
Overview
Explore the profile of Dashurie Neziri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
99
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rosalia R, Ugurov P, Neziri D, Despotovska S, Kostoska E, Veljanovska-Kiridjievska L, et al.
Blood Purif
. 2021 Jun;
51(3):233-242.
PMID: 34126617
Introduction: Coronavirus disease 2019 (COVID-19) is characterized by hyperinflammation and coagulopathy. Severe cases often develop respiratory distress, requiring mechanical ventilation and with critical cases progressing to acute respiratory distress syndrome....
2.
Ugurov P, Popevski D, Gramosli T, Neziri D, Vuckova D, Gjorgon M, et al.
Braz J Cardiovasc Surg
. 2020 Oct;
37(1):35-47.
PMID: 33113325
Introduction: Severe coronavirus disease 2019 (COVID-19) is characterised by hyperinflammatory state, systemic coagulopathies, and multiorgan involvement, especially acute respiratory distress syndrome (ARDS). We here describe our preliminary clinical experience with...
3.
Mitev K, Neziri D, Stoicovski E, Mitrev Z
J Med Case Rep
. 2018 May;
12(1):150.
PMID: 29807546
Background: The healthcare system in developing countries is limited; particularly, medical specialties such as emergency and trauma medicine are underdeveloped. Consequently, trauma injuries sustained in traffic accidents result in chronic...
4.
DDRGK1 in urine indicative of tubular cell injury in intensive care patients with serious infections
Neziri D, Pajenda S, Amuge R, Ilhan A, Wewalka M, Hormann G, et al.
J Nephropathol
. 2016 May;
5(2):65-71.
PMID: 27152292
Background: Acute kidney injury (AKI) is a life threatening condition. Despite intensive care treatment the occurrence cannot be predicted as very little indicators exist for direct measurement when tubular epithelial...
5.
Maj M, Ilhan A, Neziri D, Gartner W, Berggard T, Attems J, et al.
World J Diabetes
. 2011 May;
2(4):49-53.
PMID: 21537460
Frequent concomitant manifestation of type 2 diabetes mellitus (T2DM) and Alzheimer's disease (AD) has been recently demonstrated by epidemiological studies. This might be due to functional similarities between β-cells and...
6.
Ilhan A, Neziri D, Maj M, Mazal P, Susani M, Base W, et al.
Hum Pathol
. 2011 Feb;
42(5):641-8.
PMID: 21288557
Renal cell carcinomas are divided into several subgroups according to their histopathologic characteristics. The outcome, therapy responses, and the applicability of molecular-targeted therapies depend on the tumor classification and on...
7.
Gartner W, Ilhan A, Neziri D, Base W, Weissel M, Wohrer A, et al.
Neuro Oncol
. 2010 Apr;
12(9):1004-8.
PMID: 20378688
We detected distinct plasma concentration profiles of S100B, neuropeptide Y, and secretagogin in 3 of 191 patients enrolled in a previous study investigating brain-tissue-related markers in the blood of patients...
8.
Maj M, Gartner W, Ilhan A, Neziri D, Attems J, Wagner L
J Endocrinol
. 2010 Jan;
205(1):25-36.
PMID: 20061514
Tauopathies have been associated with Alzheimer's disease (AD), which frequently manifests together with diabetes mellitus type 2. Calcium-binding proteins such as the recently identified secretagogin (SCGN) might exert protective effects....
9.
Ilhan A, Gartner W, Neziri D, Czech T, Base W, Horl W, et al.
Anticancer Res
. 2009 Apr;
29(2):731-6.
PMID: 19331229
Background: Angiopoiesis and angiopoietic growth factors are of considerable importance in the development and progression of intracranial tumours. However, knowledge of the plasma detectability of distinct angiogenic factors in patients...